Advertisements


We are Sorry, This Page doesn't Exist


U.S. IPO Week Ahead: Unicorn Qualtrics Leads Pre-Thanksgiving Feast Of 8 IPOs

U.S. IPO Week Ahead: Unicorn Qualtrics Leads Pre-Thanksgiving Feast Of 8 IPOs.....»»

Category: topSource: seekingalphaNov 10th, 2018

Topgolf Recovering Ahead Of Plan, Callaway Capitalizing On Golf Demand

Shares of golf equipment manufacturer and Topgolf owner Callaway Golf Company (NYSE: ELY) hit new 52-week highs Tuesday after reporting first-quarter earnings. The company saw revenue at $651 million, up 47% year-over-year and w.....»»

Category: smallbizSource: nytMay 11th, 2021

Cathie Wood Adds $33.8M Shares In Shopify, Sells More Square To Pile Up Coinbase

Cathie Wood-led Ark Investment Management on Monday snapped up 28,989 shares of the Canadian e-commerce company Shopify Inc (NYSE: SHOP), worth about $33.8 million, as the stock jumped ahead of its scheduled earnings report later this week. read more.....»»

Category: blogSource: benzingaApr 27th, 2021

The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs

Biotech stocks reversed course in the week ended April 16, with the sector re.....»»

Category: blogSource: benzingaApr 17th, 2021

The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»

Category: blogSource: benzingaFeb 6th, 2021

The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»

Category: earningsSource: benzingaFeb 6th, 2021

The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna"s COVID Vaccine And Drugs From Amgen, MacroGenics

Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock reactions to presentations made at hematology and breast cancer conferences. read more.....»»

Category: blogSource: benzingaDec 13th, 2020

IPO Outlook: Popular E-commerce Company Wish, Plus Offerings From A Personal Loan Disruptor And A Biotech Firm

After the huge IPOs from AirBnB Inc (NASDAQ: ABNB) and DoorDash Inc (NYSE: DASH) last week, the week of December 13 takes a slight breather with only three IPOs scheduled and one potential blockbuster. read more.....»»

Category: blogSource: benzingaDec 13th, 2020

Unemployment claims surged to record 3.3M last week as coronavirus takes toll on economy

Filings for unemployment benefits hit a record 3.3 million last week, the Labor Department said showing the coronavirus's da.....»»

Category: topSource: usatodayMar 26th, 2020

World stocks drift as Wall Street takes a holiday

World stocks traded just below record highs Monday, pausing ahead of this week's central bank meetings, economic data and earnings, while oil prices rose to their highest in over a week after blockades began shutting down two Libyan oilfields......»»

Category: topSource: moneycentralJan 20th, 2020

World stocks drift as Wall Street takes a holiday

World stocks traded just below record highs Monday, pausing ahead of this week's central bank meetings, economic data and earnings, while oil prices rose to their highest in over a week after blockades began shutting down two Libyan oilfields......»»

Category: topSource: moneycentralJan 20th, 2020

$47M shopping center redevelopment in Leawood secures final approval

A $47 million shopping center redevelopment project in Leawood received city approval this week for its final redevelopment plans.  With the City Council's go-ahead, Ranch Mart North plans to start "large scale" construction work in the coming weeks, t.....»»

Category: topSource: bizjournalsJan 9th, 2020

Everything Jim Cramer said about the stock market on "Mad Money," including earnings reports, Costco"s China problem

CNBC's Jim Cramer takes a look at the week ahead in earnings reports. The "Mad Money" host breaks down Costco's challenges in China......»»

Category: topSource: madmoneyDec 16th, 2019

U.S. IPO Week Ahead: The Largest IPO Of The Q4, Its Sole U.S. Tech Unicorn, And Flying Taxis

U.S. IPO Week Ahead: The Largest IPO Of The Q4, Its Sole U.S. Tech Unicorn, And Flying Taxis.....»»

Category: topSource: seekingalphaDec 8th, 2019

SoftBank to go ahead with WeWork stock tender offer this week

SoftBank Group Corp will this week launch a previously agreed tender offer for as much as $3 billion of WeWork shares, including up to $970 million owned by the office sharing company's cofounder Adam Neumann, two people familiar with the matter said......»»

Category: topSource: reutersNov 24th, 2019

U.S. IPO Week Ahead: The IPO Market Takes Its Thanksgiving Break

U.S. IPO Week Ahead: The IPO Market Takes Its Thanksgiving Break.....»»

Category: topSource: seekingalphaNov 23rd, 2019

Navistar Takes $140 Million Revenue Hit From UAW-GM Strike

Navistar International Corp. (NYSE: NAV) will book a $140 million hit to fourth-quarter revenue because of the six-week United Auto Workers' strike at General Motors Co. (NYSE: GM) 0 read more.....»»

Category: blogSource: benzingaNov 14th, 2019

The Week Ahead In Biotech: Pfenex And Clinuvel On The Radar Ahead of FDA Decisions, 2 IPOs On Deck

Notwithstanding the ESMO conference generating some huge moves in some stocks, last week turned out to be a muted one for biotechs. read more.....»»

Category: blogSource: benzingaOct 6th, 2019

Everything Jim Cramer said on "Mad Money," including China trade, buy Clorox, Stitch Fix CEO, REITs

Jim Cramer takes a look at the week ahead in stock market news, including anticipation of U.S.-China trade talks, explains why Clorox is a buy and interviews Stitch Fix CEO Katrina Lake......»»

Category: topSource: madmoneyOct 4th, 2019

The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear

Biotech stocks came under selling pressure in the week ended Sept. 27 amid clinical data readouts and a handful of FDA decisions. read more.....»»

Category: blogSource: benzingaSep 29th, 2019